ArticleJournal of translational autoimmunity2023

Adding low dose cyclophosphamide to rituximab for remission-induction may prolong relapse-free survival in patients with ANCA vasculitis: A retrospective study.

Renée Ysermans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.